Valeant Pharmaceuticals (VRX) Tops Estimates

Valeant Pharmaceuticals International, Inc. (VRX) shares are up $27.07 to $200.33 in morning trading Monday after the company reported its fourth quarter earnings results. The Seattle, Washington-based firm reported earnings of $2.58 per share on revenues of $2.28 billion, up 10.5% from a year ago. Analysts were expecting EPS of $2.56 on revenues of $2.23 […] View the full post at: Valeant Pharmaceuticals (VRX) Tops Estimates Related posts: Google Reports Strong Profits